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Increased levels of interleukin-6 (IL-6) and IL-S are found in various immunologically mediated inflammatory 
disorders. Concentrations of IL-6, IL-8 and the soluble form of the IL-6 receptor (sIL-6R) were determined in serum 
and effusion fluid of 25 patients with tuberculous pleurisy utilizing enzyme linked immunosorbent assays (EIA). Serum 
IL-6 levels were only slightly increased in patients with tuberculous pleurisy in comparison to controls (11.1 & 2.1 vs 
7.3 & 1.0 pg ml I). IL-8 could not be detected in the serum of tuberculosis patients, but it was detected in the serum 
of healthy controls (8.0 & 1.5 pg ml ‘). In comparison to serum, IL-6 and IL-8 were found in high concentrations in 
pleural effusions (IL-6: 932 f 70 vs 11.1 f 2.1 pg ml - ‘, PcO.0001; IL-& 450 f 85 vs 0 f 0 pg ml-‘). In contrast, 
sIL-6R concentrations were much higher in serum compared to pleural effusion levels [30 477 f 1905 vs 
988 1 4 1177 pg ml - ‘, P<O.OOOl (mean f SEM)]. The authors conclude that elevated levels of IL-6 and IL-8 in pleural 
effusions are compartmentalized at the site of active disease. The low levels of sIL-6R in the presence of high levels of 
IL-6 in pleural effusions, and the high levels of sIL-6R in the presence of low levels of IL-6 in serum suggest that the 
expression or shedding of sIL-6R may be downregulated in the presence of excessive amounts of IL-6. 
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Introduction 
Tuberculous pleural effusions are characterized by 
increased numbers of inflammatory cells. At the early stage 
of infection, neutrophils may be present in high numbers 
(1,2). There is also evidence for selective presence of 
purified-protein-derivate (PPD)-specific T-lymphocytes at 
the site of inflammation in the early phase of infection (3). 
The selective presence of cells might contribute to the 
compartmentalization of pro-inflammatory cytokines. 
Interleukin (IL)-6 is a multifunctional cytokine playing a 
causal role in the acute phase response and the proliferation 
of several cell types (4,5). Soluble IL-6 receptor (sIL-6R) 
arises from cleavage from the cell surface and was first 
detected in the urine of normal subjects (6). IL-S is secreted 
by a variety of inflammatory cells and is a potent chemo- 
attractant and activator of neutrophils and T-lymphocytes 
(798). 
Received 29 April 1996 and accepted in revised form 6 December 
1996. 
Correspondence should be addressed to: G. Hoheisel, Department 
of Internal Medicine I, University of Leipzig, Johannisallee 32, 
D-04103 Leipzig, Germany. 
0954.6111/98/010014+04 $12.00/O 
This study measured the concentrations of IL-6 and IL-8 
in the serum and in pleural fluid of patients with tubercu- 
lous pleurisy. Furthermore, sIL-6R levels were assessed to 
determine its concentration in the pleural compartment. 
Patients and Methods 
PATIENTS 
Twenty-five patients with tuberculous pleurisy (14 men, 11 
women, age 38.4 & 4.2 years) were examined before initia- 
tion of therapy. There was no clinical evidence of HIV 
infection. None of the patients had received immuno- 
suppressive medication. The diagnosis in all patients was 
based on histological evidence of granulomatous pleuritis on 
pleural biopsy or microbiological proof of Mycobacterium 
tuberculosis in the effusion or biopsy. Tuberculin skin tests 
were not performed. The serum of 10 healthy blood donors 
(six men, four women, age 32.4 i 5.6 years) served as controls. 
COLLECTION OF PLEURAL FLUID 
Following institutional guidelines, informed consent was 
obtained from the patients. Pleural fluids were harvested 
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during the first diagnostic thoracentesis. Follow-up deter- 
minations were not performed. The total white cell and 
differential counts were determined. The cell pellet was 
separated by centrifugation (600 x g, 30 min, 4°C) and the 
lactate dehydrogenase (LDH) and total protein concen- 
trations were determined in the supernatant. Blood was 
withdrawn from a peripheral vein. The serum was separated 
by centrifugation. Blood serum and effusion supernatant 
were stored at - 70°C for later analysis. 
CYTOKINE ASSAYS 
Immunoreactive levels of IL-6, sIL-6R and IL-8 were 
determined in unconcentrated samples utilizing solid-phase 
sandwich enzyme linked immunosorbent assays (EIA) 
(human IL-6 Bio-source International, Camarillo, CA, 
U.S.A.; human sIL-6R and human IL-8: R&D Systems, 
Minneapolis, MN, U.S.A.). EIA plates were coated with 
specific murine monoclonal antibodies directed against 
either human IL-6, sIL-6R, or IL-8. Standards and cell-free 
samples were pipetted in the wells of the microtiter plates 
provided in the kits. Immunoreactive cytokine levels were 
then determined by addition of a specific horseradish 
peroxidase-linked polyclonal antibody directed against 
either human IL-6, sIL-6R, or IL-8 The minimum detect- 
able doses of IL-6, sIL-6R, or IL-8, generated by standard 
curves, were 2.0, 140.0 and 5.0 pg ml - i, respectively. 
STATISTICAL ANALYSIS 
Data are means & SEM. Statistical evaluations used the 
Mann-Whitney U-test. Correlation coefficients were calcu- 
lated using Pearson’s product moment correlation. P values 
for trend tests represent one-sided values; all other P values 
represent two-sided assessments. PcO.05 was considered 
statistically significant. 
Results 
GENERAL CHARACTERISTICS OF PLEURAL 
FLUID 
The total white cell count in 25 patients was 5963 f 2067 
cells mm-’ with 25 f 11% neutrophils and 75 f 11% 
mononuclear cells. The total protein was 51 f 2 g 1~ i and 
lactate dehydrogenase 390 & 77 IU 1~ i; demonstrating the 
exudative nature of tuberculous pleurisy. 
DETERMINATIONS OF IL-6, SIL- 6R AND IL-8 
LEVELS IN SERUM AND PLEURAL EFFUSIONS 
Values of IL-6, sIL-6R and IL-8 concentrations are illus- 
trated in Figs l-3. Serum levels of IL-6 in tuberculosis 
patients (11.1 * 2.1 pg ml - ‘) were slightly higher but with- 
out reaching statistical difference compared to healthy 
controls (7.3 f 1 .O pg ml ~ ‘); the range of values in tuber- 
culosis patients, however, was wider in comparison to 
controls (1.340.5 rs 2.6-12.4 pg ml - ‘). IL-6 levels in 
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FIG. 1. Interleukin-6 (IL-6) concentrations in serum and 
pleural effusion fluid of patients with tuberculous pleural 
effusions (n=25) and in serum of healthy controls (n= 10). 
TB, tuberculosis (mean & SEM). 
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FIG. 2. Soluble interleukin-6 receptor (sIL-6R) concen- 
trations in serum and pleural effusion fluid of patients 
with tuberculous pleural effusions (n=25). TB, tubercu- 
losis (mean * snM). 
tuberculous pleural effusions were found in high concen- 
trations (933 f 70 pg ml ~ I), significantly higher compared 
to corresponding serum levels (P<O.OOOl). IL-6 levels in 
tuberculous pleural effusions varied within a wide range 
(89-1413 pg ml ~ ‘). sIL-6R levels, in contrast, were found 
in higher concentrations in the serum of tuberculosis 
patients (30 477 f 1905 pg ml - ‘) compared to the cor- 
responding pleural effusions (9881 & 1177 pg ml- ‘) 
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FIG. 3. lnterleukin-8 (IL-Q concentrations in serum and 
pleural effusion fluid of patients with tuberculous pleural 
effusions (n=25) and in serum of healthy controls (n= 10). 
TB, tuberculosis (mean % SEM). Data are shown on a log 
scale. 
(WO.0001). There was a relatively wider range in pleural 
effusion levels in comparison to serum levels (124-8452 YS 
17 776-51 120 pg ml - I). Serum slL-6R levels correlated 
positively with pleural slL-6R levels (r=0.554; P<O,Ol). 
IL-8 could not be detected in the serum of tuberculosis 
patients. In contrast, IL-8 was detected in low levels in the 
serum of healthy controls (8.0 f 1.5 pg ml- ‘); the values 
ranged from 2.6 to 15.9 pg ml - I. IL-8 was found in high 
amounts in tuberculous pleural effusions (450 * 85 pg 
ml - ‘), with values ranging widely from 0 to 1347 pg ml - ‘. 
No correlation was found between cytokine levels and cell 
differential counts. 
Discussion 
High concentrations of IL-6 and IL-8 were found in the 
pleural fluid of patients with tuberculosis when compared 
to corresponding serum concentrations. This study there- 
fore indicates that in tuberculous pleurisy, IL-6 and IL-8 
are compartmentalized at the site of active disease. In 
contrast, slL-6R is found in much lower concentrations in 
the pleural compartment when compared to serum. 
Elevated levels of IL-6 in pleural effusions of tuberculosis 
patients corresponded with lower levels in serum. In con- 
trast, high levels of slL-6R were found in serum but not in 
pleural effusions. 
In agreement with previous reports, IL-6 and IL-8 were 
found in high concentrations in the pleural compartment in 
tuberculosis patients (7,9). In the present study, IL-8 was 
not detectable in serum but was found in high amounts in 
the pleural compartment of tuberculosis patients. IL-8 is a 
potent activator of neutrophil functions including chemo- 
taxis and, in addition, a chemo-attractant for activated 
lymphocytes (10). In agreement with the authors’ data, 
pleural effusions in tuberculosis contain predominantly 
mononuclear cells. It has been demonstrated before that 
activated T-cells are compartmentalized to the pleural space 
in tuberculous pleurisy (3,ll). 
Regulation of the shedding of the membrane-bound 
IL-6R and the function and significance of the resulting 
soluble IL-6 receptor (slL-6R) in biological fluids is not 
currently understood. It has been suggested that patho- 
logical states correlating with elevated levels of IL-6 may 
be associated with increased production of slL-6R (12). 
However, levels of slL-6R were not increased in tubercu- 
lous pleural effusions (13). The assay used to determine 
slL-6R in the present study has been shown to be 
insensitive to added human recombinant IL-6, suggesting 
that the measurement corresponds to the total amount 
of free receptor plus the total amount of receptor bound 
to IL-6. These results might allow speculation that the 
shedding of slL-6R is downregulated in the presence of 
excessive amounts of IL-6, rendering target cells less 
responsive to the IL-6/slL-6R complex, or that all 
sIL-6R has already interacted with IL-6 and is bound to 
cells. 
The authors conclude from this study that IL-6 
and IL-8 levels are elevated in tuberculous pleural effusions 
when compared to serum levels. These data confirm reports 
of compartmentalization of these cytokines at the site of 
active disease, suggesting that IL-6 and IL-8 might be 
synthesized and released after phagocytosis of M. tubercu- 
losis by macrophages followed by activation of inflamma- 
tory cells participating in the process of containment of the 
pathogen. The low levels of slL-6R in the presence of high 
of levels of IL-6 in pleural effusions and the high levels of 
slL-6R in the presence of low levels of IL-6 in serum may 
suggest that the cell-surface expression or shedding of 
sIL-6R is downregulated in the presence of excessive 
amounts of IL-6, rendering target cells less responsive to the 
IL-6/slL-6R complex. 
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